EHP-101

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Product Details
Company Profile

Min.Order :0
Purity: ≥98%

Keywords

VCE-004.8 (1'R,6'R)-3-(benzylamino)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione

Quick Details

Appearance:Solid Powder
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:Store at -20°C
Transportation:

Superiority:

We provide customized and high-quality EHP-101 product for your project.

Details:

EHP-101 is an orally active, specific PPARγ and CB2 receptor dual agonist that inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. HP-101 is a semi-synthetic multi-target cannabinoquinoid with potent anti-inflammatory activity. It attenuates adipogenesis and prevents diet-induced obesity.

View All